What's New

1 September 2021

At the meeting of 4 August 2021 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
fibrosing interstitial lung disease 85/2021 86/2021
polycythaemia vera 87/2021 88/2021
primary myelofibrosis 89/2021 90/2021
essential thrombocythaemia 91/2021 92/2021
carpal tunnel syndrome 93/2021 94/2021
myeloma 95/2021 96/2021

These SOPs revoke the SOPs previously determined for these conditions.

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
ischaemic heart disease 97/2021 98/2021

Note: Ischaemic heart disease Amendment Statement of Principles No. 98 of 2021 will be published shortly.

The above SOPs take effect from 20 September 2021.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
aortic stenosis Intention to remove one or more factors December 2021
colorectal adenoma Intention to remove one or more factors December 2021

Finalised Declarations for:

Condition Declaration Reasons for Decision
malignant neoplasm of the brain
malignant neoplasm of the prostate

Completed Investigations

The above determinations and declarations conclude the previously advertised investigations into:

New Investigations

Decided to advertise the following investigations:

The above declaration and investigation notices appear in the Government Notices Gazette of 31 August 2021.